$HTFL

Why is Heartflow stock surging today?

Investing.com reports Heartflow (HTFL) shares rose 16.1% in after-hours to $36 after its Q2 results beat expectations. Adjusted loss per share was -$0.07 vs -$0.19 consensus. Revenue was $64.1M, up 48% YoY. Full-year 2026 revenue guidance was raised to $246M-$250M. CEO John Farquhar sold 22,562 shares under a Rule 10b5-1 plan.

Original reporting
Published Aug 13, 2026, 9:48 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 10:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HTFL
Bullish
high confidence
Mentioned
$HTFL
Relevance
9/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$HTFLBullishHigh
01

Why it matters

HTFL’s after-hours jump is tied to a quantified earnings beat (adjusted loss per share) and a sizable revenue growth rate, plus a raised guidance range that signals stronger commercial traction.

02

Market read

A quantified earnings and guidance beat is a direct catalyst for HTFL positioning, likely prompting rapid repricing and momentum trading.

03

What to watch

The article notes a routine 10b5-1 CEO sale; traders may still want to monitor whether any additional competitive developments (e.g., Cleerly litigation) emerge.

Relevance 9/10Novelty 9/10Timing: after-hours reaction following Q2 earnings and same-day guidance raise

Background

The piece frames HTFL’s rally as primarily driven by its Q2 results and an upward revision to full-year 2026 revenue guidance.

Company-level read

Ticker impact

$HTFLBullishHigh confidence
Context

Heartflow (HTFL) surged after-hours on a Q2 earnings beat and raised full-year 2026 revenue guidance to $246M-$250M.

Expected impact

Near-term upside bias with elevated volatility; follow-through depends on whether investors treat the raised range as credible versus prior outlook.

Evidence & confidence

The article cites specific EPS, revenue growth, and a concrete full-year guidance increase, which are direct drivers of valuation and positioning.

Market effects

Positive read-through for AI cardiac diagnostics and medical technology sentiment, though the article provides no new sector-wide policy or trial data.

No meaningful regional spillover described; broader U.S. indices were nearly flat.

No global catalysts mentioned beyond company-specific results.

Counterpoint

The stock’s move may be driven by one quarter’s beat and guidance lift, which could still face execution risk if adoption slows.

Key entities

  • Heartflow

    AI-powered cardiac diagnostics company whose Q2 results and raised 2026 revenue guidance drove the after-hours surge.

  • Cleerly

    Competitor mentioned in the context of a prior patent infringement suit, with no new news reported today.

  • John Farquhar

    CEO who sold shares under a pre-scheduled Rule 10b5-1 plan on August 10.

Related articles

$HTFLMed

Heartflow, Inc. (HTFL): Results of Operations and Financial Condition

Heartflow, Inc. (HTFL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 htfl-20260813xex99_1.htm EX-99.1 Exhibit 991 20260813 Exhibit 99.1 Heartflow Reports Second Quarter 202 6 Financial Results and Raises Full Year 2026 Guidance SAN FRANCISCO — August 1 3 , 202 6 – Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology fo

$ARMKMedAI 8/10

Why Aramark (ARMK) Stock Is Up Today

Aramark (NYSE:ARMK) shares rose about 9.8% after the company reported better-than-expected Q3 2026 results. Revenue was $5.06B, up 9.3% year over year, and adjusted EPS was $0.52 above consensus. Free cash flow turned positive at $8.69M versus a $33.55M loss a year earlier.

$STNEMed

Why is StoneCo stock sliding today?

StoneCo Ltd shares fell 2% in after-hours after its Q2 2026 results beat adjusted EPS but missed revenue. Adjusted EPS was R$2.40, in line with consensus, while revenue was R$3.59B vs R$3.67B expected. Adjusted net income fell 2.6% YoY to R$582.7M. Investors cited a 107.5% YoY jump in its credit portfolio and concerns tied to Brazil’s high rates.

$ETONHighAI 9/10

Why is Eton Pharmaceuticals stock surging today?

Eton Pharmaceuticals shares rose about 20% in after-hours after it reported Q2 2026 results. Revenue nearly doubled to $37.6M versus $26.88M consensus, and adjusted EPS was $0.43 versus $0.15 estimate. The company raised full-year 2026 revenue guidance to over $145M. Adjusted EBITDA increased to $16.2M, and H.C. Wainwright lifted its price target to $65 from $57.

$TMCMedAI 8/10

Why is TMC the metals company stock sliding today?

Investing.com reports TMC the metals company shares fell 3.2% in after-hours after its Q2 2026 results. TMC posted a net loss of $0.14 per share versus $0.06 expected, with revenue at zero. Exploration and evaluation expenses rose to $56.1M from $10.5M, including a $37.2M Allseas settlement. Liquidity was about $143M; it targets permits in Q1 2027 and commissioning in Q4 2027.

$GOMedAI 8/10

Grocery Outlet (GO) Stock Trades Up, Here Is Why

Grocery Outlet (NASDAQ: GO) shares rose 8.8% after the company reported Q2 FY2026 adjusted EPS of $0.20 versus $0.12 to $0.13 expected, and net sales of $1.19B above forecasts. It raised FY2026 guidance to net sales of $4.70B-$4.72B and adjusted EPS of $0.51-$0.55. Shares later closed at $10.78, up 5.2%.

Why is Heartflow stock surging today? — alphai